Expression of the chemokine receptor CCR1 in human renal allografts

Nephrology Dialysis Transplantation

Volumn 22, Issue 6, 2007, Pages 1720-1729

  Mayer, Verena ^a   Hudkins, Kelly L ^b   Heller, Florian ^a   Schmid, Holger ^a   Kretzler, Matthias ^a   Brandt, Ulrike ^a   Anders, Hans Joachim ^a   Regele, Heinz ^c   Nelson, Peter J ^a   Alpers, Charles E ^b   Schlöndorff, Detlef ^a   Segerer, Stephan ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

Allograft rejection; CCL5; CCR1; CD20; Chemokines; DC SIGN

Indexed keywords

CD20 ANTIGEN; CD209 ANTIGEN; CD3 ANTIGEN; CD68 ANTIGEN; CHEMOKINE RECEPTOR CCR1; CORTICOSTEROID; CREATININE; CYCLOSPORIN A; FORMALDEHYDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PARAFFIN; PROTEIN S 100; RANTES; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; AGED; ARTICLE; B LYMPHOCYTE; CELL MIGRATION; CELLULAR DISTRIBUTION; CHRONIC GRAFT REJECTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; CREATININE BLOOD LEVEL; DENDRITIC CELL; DOWN REGULATION; FEMALE; GLOMERULUS CAPILLARY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; KIDNEY CELL; KIDNEY TRANSPLANTATION; MACROPHAGE; MALE; MONOCYTE; NEPHRECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RENAL GRAFT DYSFUNCTION; STATISTICAL SIGNIFICANCE;

ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD20; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; B-LYMPHOCYTE SUBSETS; BOWMAN CAPSULE; CELL ADHESION MOLECULES; DENDRITIC CELLS; FEMALE; HUMANS; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; KIDNEY TUBULES; LECTINS, C-TYPE; MALE; MIDDLE AGED; MONOCYTES; RECEPTORS, CELL SURFACE; RECEPTORS, CHEMOKINE; TRANSPLANTATION, HOMOLOGOUS;

EID: 34447576795     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm007     Document Type: Article

References (51)

1. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 1994; 76: 301-314
2. Segerer S, Nelson PJ, Schlondorff D. Chemokines, chemokine receptors, and renal disease: From basic science to pathophysiologic and therapeutic studies. J Am Soc Nephrol 2000; 11: 152-176
3. Ley K. Arrest chemokines. Microcirculation 2003; 10: 289-295
4. Segerer S. The role of chemokines and chemokine receptors in progressive renal diseases. Am J Kidney Dis 2003; 41: S15-S18
5. Inston NG, Cockwell P. The evolving role of chemokines and their receptors in acute allograft rejection. Nephrol Dial Transplant 2002; 17: 1374-1379
6. Haskell CA, Ribeiro S, Horuk R. Chemokines in transplant rejection. Curr Opin Investig Drugs 2002; 3: 399-405
7. Zheng G, Wang Y, Mahajan D et al. The role of tubulointerstitial inflammation. Kidney Int Suppl 2005; S96-100
8. Colvin BL, Thomson AW. Chemokines, their receptors, and transplant outcome. Transplantation 2002; 74: 149-155
9. Murphy PM, Baggiolini M, Charo IF et al. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev 2000; 52: 145-176
10. Dalton RS, Webber JN, Pead P, Gibbs PJ, Sadek SA, Howell WM. Immunomonitoring of renal transplant recipients in the early posttransplant period by sequential analysis of chemokine and chemokine receptor gene expression in peripheral blood mononuclear cells. Transplant Proc 2005; 37: 747-751
11. Weber C, Weber KS, Klier C et al. Specialized roles of the chemokine receptors CCR1 and CCR5 in the recruitment of monocytes and T(H)1-like/CD45RO(+) T cells. Blood 2001; 97: 1144-1146
12. Katschke KJ,Jr, Rottman JB, Ruth JH et al. Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis. Arthritis Rheum 2001; 44: 1022-1032
13. Anders HJ, Ninichuk V, Schlondorff D. Progression of kidney disease: blocking leukocyte recruitment with chemokine receptor CCR1 antagonists. Kidney Int 2006; 69: 29-32
14. Yun JJ, Whiting D, Fischbein MP et al. Combined blockade of the chemokine receptors CCR1 and CCR5 attenuates chronic rejection. Circulation 2004; 109: 932-937
15. Grone HJ, Weber C, Weber KS et al. Met-RANTES reduces vascular and tubular damage during acute renal transplant rejection: Blocking monocyte arrest and recruitment. Faseb J 1999; 13: 1371-1383
16. Horuk R, Shurey S, Ng HP et al. CCR1-specific non-peptide antagonist: Efficacy in a rabbit allograft rejection model. Immunol Lett 2001; 76: 193-201
17. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713-723
18. Segerer S, Hughes E, Hudkins KL, Mack M, Goodpaster T, Alpers CE. Expression of the fractalkine receptor (CX3CR1) in human kidney diseases. Kidney Int 2002; 62: 488-495
19. Segerer S, Cui Y, Eitner F et al. Expression of chemokines and chemokine receptors during human renal transplant rejection. Am J Kidney Dis 2001; 37: 518-531
20. Ruster M, Sperschneider H, Funfstuck R, Stein G, Grone HJ. Differential expression of beta-chemokines MCP-1 and RANTES and their receptors CCR1, CCR2, CCR5 in acute rejection and chronic allograft nephropathy of human renal allografts. Clin Nephrol 2004; 61: 30-39
21. Segerer S, Bohmig GA, Exner M et al. When renal allografts turn darc. Transplantation 2003; 75: 1030-1034
22. Flugel A, Berkowicz T, Ritter T et al. Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis. Immunity 2001; 14: 547-560
23. Shang X, Qiu B, Frait KA et al. Chemokine receptor 1 knockout abrogates natural killer cell recruitment and impairs type-1 cytokines in lymphoid tissue during pulmonary granuloma formation. Am J Pathol 2000; 157: 2055-2063
24. Sorensen TL, Tani M, Jensen J et al. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J Clin Invest 1999; 103: 807-815
25. Segerer S, Banas B, Wornle M et al. CXCR3 is involved in tubulointerstitial injury in human glomerulonephritis. Am J Pathol 2004; 164: 635-649
26. Segerer S, Henger A, Schmid H et al. Expression of the chemokine receptor CXCR1 in human glomerular diseases. Kidney Int 2006; 69: 1765-1773
27. Schmid H, Cohen CD, Henger A, Irrgang S, Schlondorff D, Kretzler M. Validation of endogenous controls for gene expression analysis in microdissected human renal biopsies. Kidney Int 2003; 64: 356-360
28. Schmid H, Cohen CD, Henger A, Schlondorff D, Kretzler M. Gene expression analysis in renal biopsies. Nephrol Dial Transplant 2004; 19: 1347-1351
29. Schmid H, Henger A, Cohen CD et al. Gene expression profiles of podocyte-associated molecules as diagnostic markers in acquired proteinuric diseases. J Am Soc Nephrol 2003; 14: 2958-2966
30. Giulietti A, Overbergh L, Valckx D, Decallonne B, Bouillon R, Mathieu C. An overview of real-time quantitative PCR: Applications to quantify cytokine gene expression. Methods 2001; 25: 386-401
31. Gao W, Topham PS, King JA et al. Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection. J Clin Invest 2000; 105: 35-44
32. Pease JE, Horuk R. CCR1 antagonists in clinical development. Expert Opin Investig Drugs 2005; 14: 785-796
33. Anders HJ, Vielhauer V, Frink M et al. A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation. J Clin Invest 2002; 109: 251-259
34. Eis V, Luckow B, Vielhauer V et al. Chemokine receptor CCR1 but not CCR5 mediates leukocyte recruitment and subsequent renal fibrosis after unilateral ureteral obstruction. J Am Soc Nephrol 2004; 15: 337-347
35. Vielhauer V, Berning E, Eis V et al. CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome. Kidney Int 2004; 66: 2264-2278
36. Anders HJ, Belemezova E, Eis V et al. Late onset of treatment with a chemokine receptor CCR1 antagonist prevents progression of lupus nephritis in MRL-Fas(lpr) mice. J Am Soc Nephrol 2004; 15: 1504-1513
37. Ninichuk V, Gross O, Reichel C et al. Delayed chemokine receptor 1 blockade prolongs survival in collagen 4A3-deficient mice with Alport disease. J Am Soc Nephrol 2005; 16: 977-985
38. Bedke J, Kiss E, Schaefer L et al. Beneficial effects of CCR1 blockade on the progression of chronic renal allograft-damage. Am J Transplant 2007 (in press)
39. Elices MJ. BX-471 Berlex. Curr Opin Investig Drugs 2002; 3: 865-869
40. Talvani A, Rocha MO, Ribeiro AL, Correa-Oliveira R, Teixeira MM. Chemokine receptor expression on the surface of peripheral blood mononuclear cells in Chagas disease. J Infect Dis 2004; 189: 214-220
41. Phillips RJ, Lutz M, Premack B. Differential signaling mechanisms regulate expression of CC chemokine receptor-2 during monocyte maturation. J Inflamm 2005; 2: 14
42. Masaki T, Chow F, Nikolic-Paterson DJ, Atkins RC, Tesch GH. Heterogeneity of antigen expression explains controversy over glomerular macrophage accumulation in mouse glomerulonephritis. Nephrol Dial Transplant 2003; 18: 178-181
43. Kluth DC, Erwig LP, Rees AJ. Multiple facets of macrophages in renal injury. Kidney Int 2004; 66: 542-557
44. Bruhl H, Wagner K, Kellner H, Schattenkirchner M, Schlondorff D, Mack M. Surface expression of CC- and CXC-chemokine receptors on leucocyte subsets in inflammatory joint diseases. Clin Exp Immunol 2001; 126: 551-559
45. Corcione A, Tortolina G, Bonecchi R et al. Chemotaxis of human tonsil B lymphocytes to CC chemokine receptor (CCR) 1, CCR2 and CCR4 ligands is restricted to non-germinal center cells. Int Immunol 2002; 14: 883-892
46. Kerjaschki D, Regele HM, Moosberger I et al. Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J Am Soc Nephrol 2004; 15: 603-612
47. Sarwal M, Chua MS, Kambham N et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med 2003; 349: 125-138
48. Varani S, Frascaroli G, Homman-Loudiyi M, Feld S, Landini MP, Soderberg-Naucler C. Human cytomegalovirus inhibits the migration of immature dendritic cells by downregulating cell-surface CCR1 and CCR5. J Leukoc Biol 2005; 77: 219-228
49. Jugde F, Boissier C, Rougier-Larzat N et al. Regulation by allergens of chemokine receptor expression on in vitro-generated dendritic cells. Toxicology 2005; 212: 227-238
50. Bariety J, Nochy D, Mandet C, Jacquot C, Glotz D, Meyrier A. Podocytes undergo phenotypic changes and express macrophagic-associated markers in idiopathic collapsing glomerulopathy. Kidney Int 1998; 53: 918-925
51. Grau V, Gemsa D, Steiniger B, Garn H. Chemokine expression during acute rejection of rat kidneys. Scand J Immunol 2000; 51: 435-440